InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tevogen Inc.

TVGN Clue Score25
United States Fiscal year ends December CIK 0001860871
$6.78 -3.97% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.78 +818.57% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 15 Feb 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Net income4.4Fiscal year 2023Operating income−8.8Net income−60.5 −1,471.9%EPS, diluted−2.44Fiscal year 2024Operating income−53.6Net income−13.7EPS, diluted−3.50Fiscal year 2025Operating income−26.1Net income−26.3EPS, diluted−8.08
FY2022FY2023FY2024FY2025
Operating income n/a −8.8 −53.6 −26.1
Net income 4.4 −60.5 −13.7 −26.3
Growth −1,471.9%
EPS, diluted n/a −2.44 −3.50 −8.08

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−0.2Fiscal year 2023Operating cash flow−8.2Capital expenditure−0.1Free cash flow−8.3Buybacks−343.0Fiscal year 2024Operating cash flow−12.0Fiscal year 2025Operating cash flow−12.3Capital expenditure−0.1Free cash flow−12.4
FY2022FY2023FY2024FY2025
Operating cash flow −0.2 −8.2 −12.0 −12.3
Capital expenditure n/a −0.1 n/a −0.1
Free cash flow n/a −8.3 n/a −12.4
Growth
Buybacks n/a −343.0 n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash0.1Shareholders’ equity−34.0Fiscal year 2023Cash0.0Shareholders’ equity−94.4Fiscal year 2024Cash0.0Shareholders’ equity−6.7Fiscal year 2025Cash0.0Shareholders’ equity−8.2
FY2022FY2023FY2024FY2025
Cash 0.1 0.0 0.0 0.0
Shareholders’ equity −34.0 −94.4 −6.7 −8.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
1.2% −1,098.5% −396.6% −599.5%
Balance and payout
4.2% 1,815.2% 292.8% 287.9%